Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly

被引:37
作者
Colao, Annamaria
Pivonello, Rosario
Cavallo, Luigi M.
Gaccione, Maria
Auriemma, Renata S.
Esposito, Felice
Cappabianca, Paolo
Lombardi, Gaetano
机构
[1] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Neurol Sci, Neurosurg Sect, I-80131 Naples, Italy
关键词
SPONTANEOUS GH SECRETION; DISEASE-ACTIVITY; OCTREOTIDE; MORTALITY; SURGERY; THERAPY;
D O I
10.1111/j.1365-2265.2006.02584.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background This analytical, retrospective study was designed to select cut-off thresholds of mean GH levels during a diurnal profile and nadir GH levels after oral glucose tolerance test (OGTT) according to age to diagnose surgical remission of acromegaly. Methods One hundred forty-one patients (76 women, aged 44 +/- 15 years and 65 men, aged 43 +/- 13 years) were included in this study. For the purpose of this study, remission was based on insulin-like growth factor-I (IGF-I) levels in the normal range for age. Diagnostic accuracy was analysed by receiving-operator characteristics (ROC) curves in the entire series, and in young (20-40 years), middle-aged (41-60 years) and older patients (> 60 years), separately. Results Sixty patients (42.6%) had normal IGF-I levels after surgery. In the entire series, in young and in middle-aged patients, the ROC analysis showed that optimum cut-off for mean GH levels was 2.3 mu g/l (diagnostic accuracy range, 94-97%) whereas that for nadir GH after OGTT were, respectively, 0.85, 0.9 and 0.8 mu g/l (diagnostic accuracy range, 90-95%). In the older patients, the optimum cut-off selected for mean GH levels was 1.4 mu g/l and that for nadir GH after OGTT was 0.5 mu g/l (diagnostic accuracy, 100% for both). The comparative analysis of the ROC curves did not show any significant difference between mean GH and nadir GH after OGTT (P = 0.21). Conclusions The criteria currently accepted for diagnosing post-surgical remission of acromegaly have high diagnostic accuracy only in the patients aged below 60 years. In older patients, lower cut-offs (i.e. = 1.4 mu g/l for fasting GH and = 0.5 mu g/l for nadir GH after OGTT) predict normal IGF-I levels. Mean GH levels during a diurnal profile have similar diagnostic accuracy of nadir GH levels after OGTT. This suggests that OGTT is not necessary to establish surgical cure.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 1996, World Health Organ Tech Rep Ser, V862, P1
[2]  
[Anonymous], 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation-Part 1: Diagnosis and Classification of Diabetes Mellitus
[3]   Biochemical assessment and long-term monitoring in patients with acromegaly: Statement from a joint consensus conference of The Growth Hormone Research Society and The Pituitary Society [J].
Bengtsson, BA ;
Carlsson, L ;
Christianssen, JS ;
Clemmons, D ;
Frohman, L ;
Ho, K ;
Mullis, PE ;
Robinson, I ;
Strasburger, CJ ;
Thorner, MO ;
Vance, ML ;
von Werder, K ;
Freda, PU ;
Holdaway, I ;
Johansson, G ;
Jorgensen, JOL ;
Wass, J ;
Barkan, A ;
Brue, TC ;
Chihara, K ;
Colao, A ;
de Herder, WW ;
Malozowski, S ;
Molitch, ME ;
Orskov, H ;
Schopohl, J ;
Shalet, SM ;
Stewart, PM ;
Swearingen, B ;
Trainer, PJ ;
Anderberg, B ;
Baister, L ;
Friend, KE ;
Harris, PE ;
Hartman, ML ;
Ispas-Jouron, S ;
Kappelgaard, AM ;
Knudsen, KW ;
Konno, T ;
Loumaye, E ;
Musgrave, D ;
Olivier, C ;
Pedroncelli, A ;
Shimatsu, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3099-3102
[4]   Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor I measurements [J].
Biermasz, NR ;
Dekker, FW ;
Pereira, AM ;
van Thiel, SW ;
Schutte, PJ ;
van Dulken, H ;
Romijn, JA ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2789-2796
[5]   Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women [J].
Burman, P ;
Johansson, AG ;
Siegbahn, A ;
Vessby, B ;
Karlsson, FA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :550-555
[6]  
Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0
[7]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[8]   EVALUATION OF ACROMEGALY BY RADIOIMMUNOASSAY OF SOMATOMEDIN-C [J].
CLEMMONS, DR ;
VANWYK, JJ ;
RIDGWAY, EC ;
KLIMAN, B ;
KJELLBERG, RN ;
UNDERWOOD, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (21) :1138-1142
[9]   First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial [J].
Colao, A ;
Pivonello, R ;
Rosato, F ;
Tita, P ;
Menis, E ;
Barreca, A ;
Ferrara, R ;
Mainini, F ;
Arosio, M ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 2006, 64 (03) :342-351
[10]   Gender- and age-related differences in the endocrine parameters of acromegaly [J].
Colao, A ;
Amato, G ;
Pedroncelli, AM ;
Baldelli, R ;
Grottoli, S ;
Gasco, V ;
Petretta, M ;
Carella, C ;
Pagani, G ;
Tamburano, G ;
Lombardi, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (06) :532-538